Hanyang Med Rev.  2011 Aug;31(3):141-152. 10.7599/hmr.2011.31.3.141.

Multidrug-resistant Organisms and Healthcare-associated Infections

Affiliations
  • 1Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Seoul, Korea. mnkim@amc.seoul.kr

Abstract

Multidrug-resistant organisms (MDROs), including methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-resistnat Staphlyococcus aureus (VRSA), vancomycin-resistant enterococci (VRE), multidrug-resistant Acinetobacter baumannii, and multidrug resistant Pseudomonas aeruginosa have been a big challenge in control of healthcare-associated infection for a few decades in Korea. Carbapenem-resistant Enterobacteriaceae was most recently added to the utmost threatening MDROs. Because of the high and ever increasing level of MDROs and their healthcare-associated infections, prevention and control of MDROs has become a national priority. The above six MDROs have been designated as legislative healthcare-associated infections, which has to be reported to the Korean Center for Disease Control since January 2011 in Korea. This paper is provided to give current perspectives of MDROs and their healthcare-associated infections in Korea.

Keyword

Drug Resistance, Multiple, Bacteria; Infection Control; Methicillin-resistant Staphylococcus aureus; Vancomycin; Carbapenems

MeSH Terms

Acinetobacter baumannii
Carbapenems
Centers for Disease Control and Prevention (U.S.)
Enterobacteriaceae
Infection Control
Korea
Methicillin-Resistant Staphylococcus aureus
Pseudomonas aeruginosa
Vancomycin
Carbapenems
Vancomycin
Full Text Links
  • HMR
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr